Description | | Purified Monoclonal Antibody against Lymphatic Endothelial Marker (Formerly Signet Catalog Nos: 730-001, 730-01, 730-16 L1 Predilute, 730-26 L2 Predilute) |
Intended Use | | ** In Vitro Diagnostic (IVD) ** |
Clone | | D2-40 |
Form | | Purified Antibody (in 0.01M PBS + 0.1% NaN3 + 1% BSA) |
Host | | Mouse |
Species Reactivity | | Human |
IsoType | | D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)IgG1 |
Specificity | | Clone D2-40 reacts with a O-linked sialoglycoprotein (MW 40kDa) found on lymphatic endothelium, fetal testis and on the surface of testicular germ cell tumors. In recent studies clone D2-40 (D240) has shown staining in lymphatic channel endothelium but not in the adjacent capillary. This antibody was developed using M2A. Concentrated Format: SIG-3730-100 [0.1 mL] SIG-3730-1000 [1 mL] Prediluted Formats: SIG-3730-16 [6 mL] SIG-3730-26 [6 mL] Both are ready-to-use with either a Biotin-based (USA Ultra Streptavidin Detection, SIG-32250) or Biotin-free (ACUITYAdvanced Polymer Detection, SIG-32902) detection systems. |
Uses | | This antibody is effective in immunoblotting and immunohistochemistry (IHC). |
Suggested Working Dilution | | The optimal working dilution should be determined for each specific assay condition. - Western blot: 0.1 - 0.5 ug/mL
- IHC: ≥1:40 (concentrated format) for Biotin based detection systems such as USA Ultra Streptavidin Detection (SIG-32250).
Tissue Sections: Formalin-fixed, paraffin-embedded tissues, frozen sections Pretreatment: Not required Incubation: 60 minutes at room temperature |
Storage | | D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)Store between 2-8°C. |
References | | Choi WW, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF family gene expression. Mod Pathol 18:143-52, 2005. Chu, AY, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105-110, 2005. Dumoff KL, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 18:97-104, 2005. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Ped Dev Pathol 8(2):181-9, 2005. Fogt F, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 11:47-50, 2004. Fogt F, et al. Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: A form fruste of lymphangiogenesis? Int J Molec Med 13:681-683, 2004. Franchi A, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma.Cancer 101(5):973-978, 2004. Franke FE, et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol 31:362-367, 2004. Giorgadze TA, et al. Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol 31:672-677, 2004. |
Warranty/Conditions | | Covance products may not be resold or modified for resale without prior written approval. |